文献速递血栓与止血

ISTH出血评估工具预测遗传性血小板疾病出血事件

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology.
PubMed 文献 · J Thromb Haemost · 2021-01-01

基于BAT-VAL研究对955例遗传性血小板疾病、1型血管性血友病及健康对照进行2年前瞻性随访,发现基线ISTH-BAT出血评分越高,后续需治疗出血事件风险越高,尤其在遗传性血小板功能疾病中。

要点

  • 基线出血评分高的遗传性血小板功能疾病患者随访期需治疗出血事件更多。
  • 出血事件发生率随基线出血评分四分位数升高而增加。
  • 基线出血评分与严重出血风险相关,在儿童人群中结果相似。

核心结论

  • 遗传性血小板功能疾病患者入组时高出血评分与随访期需治疗出血事件风险增加相关。
  • 基线出血评分四分位数越高,后续出血事件发生率越高,提示高评分独立于诊断与后续出血风险相关。

研究设计与样本

  • BAT-VAL研究为前瞻性队列,纳入遗传性血小板疾病、1型血管性血友病及年龄性别匹配健康对照,随访2年。
  • 初始入组1098例,955例完成随访,记录需治疗的出血事件。

主要发现

  • 随访期间124例发生出血,其中60%为遗传性血小板功能疾病。
  • 遗传性血小板功能疾病出血事件总数235例,高于1型血管性血友病的52例和遗传性血小板减少症的20例。
  • 需输血事件在遗传性血小板功能疾病中占66%,1型血管性血友病中占5.7%,遗传性血小板减少症中占3%。
  • 遗传性血小板功能疾病中,随访发生出血者基线出血评分显著高于未出血者(p < .01)。
  • 出血事件发生率随基线出血评分四分位数升高而增加;出血评分与严重出血风险在总体、遗传性血小板功能疾病和1型血管性血友病人群中显著相关。

临床怎么用

  • 对遗传性血小板疾病患者可采用ISTH-BAT基线出血评分识别后续高出血风险者。
  • 基线出血评分高的遗传性血小板功能疾病患者需加强随访和出血监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ISTH Bleeding Assessment Tool (ISTH-BAT) has been validated for clinical screening of suspected von Willebrand disease (VWD) and for bleeding prediction. Recently it has been validated for subjects with inherited platelet disorders (IPD) (BAT-VAL study). OBJECTIVES: To determine whether the ISTH-BAT bleeding score (BS) predicts subsequent bleeding events requiring treatment in IPD patients. METHODS: Patients with IPD, type 1 VWD (VWD-1) and age- and sex-matched healthy controls enrolled in the BAT-VAL study were prospectively followed-up for 2 years and bleeding episodes requiring treatment were recorded. RESULTS: Of the 1098 subjects initially enrolled, 955 were followed-up and 124 suffered hemorrhages during follow-up, 60% of whom had inherited platelet function disorders (IPFD). Total number of events was significantly higher in IPFD (n = 235) than VWD-1 (n = 52) or inherited thrombocytopenia (IT; n = 20). Events requiring transfusions were 66% in IPFD, 5.7% in VWD-1, and 3% in IT. Baseline BS was significantly higher in IPFD patients with a bleeding event at follow-up than in those without (p < .01) and the percentage of subjects suffering a bleeding event increased proportionally to baseline BS quartile. A significant association between the BS and the chance of suffering severe bleeding was found in the overall, IPFD, and VWD-1 populations. Similar results were obtained for the pediatric population. CONCLUSIONS: Inherited platelet function disorder patients with high BS at enrollment are more likely to suffer from bleeding events requiring treatment at follow-up. Moreover, the higher the baseline BS quartile the greater the incidence of subsequent events, suggesting that independently from diagnosis a high BS is associated with a greater risk of subsequent hemorrhage.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Gresele P, Falcinelli E, Bury L, et al. The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. 2021. PMID: 33880867. doi:10.1111/jth.15263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。